S-Palmitoylation of Tyrosinase at Cysteine500 Regulates Melanogenesis
S-Palmitoylation of Tyrosinase at Cysteine500 Regulates Melanogenesis
复制标题
DOI:
10.1016/j.jid.2022.08.040
复制
发表时间:
2023-01-19
影响因子:
6.5
通讯作者:
Ueyama, Takehiko
中科院分区:
文献类型:
--
作者:
Niki, Yoko;Adachi, Naoko;Ueyama, Takehiko
Palmitoylation is a lipid modification involving the attachment of palmitic acid to a cysteine residue, thereby affecting protein function. We investigated the effect of palmitoylation of tyrosinase, the rate-limiting enzyme in melanin synthesis, using a human three-dimensional skin model system and melanocyte culture. The pal-mitoylation inhibitor, 2-bromopalmitate, increased melanin content and tyrosinase protein levels in melano-genic cells by suppressing tyrosinase degradation. The palmitoylation site was Cysteine500 in the C-terminal cytoplasmic tail of tyrosinase. The nonpalmitoylatable mutant, tyrosinase (C500A), was slowly degraded and less ubiquitinated than wild-type tyrosinase. Screening for the Asp-His-His-Cys (DHHC) family of proteins for tyrosinase palmitoylation suggested that DHHC2, 3, 7, and 15 are involved in tyrosinase palmitoylation. Knockdown of DHHC2, 3, or 15 increased tyrosinase protein levels and melanin content. Determination of their subcellular localization in primary melanocytes revealed that DHHC2, 3, and 15 were localized in the endo-plasmic reticulum, Golgi apparatus, and/or melanosomes, whereas only DHHC2 was localized in the melano-somes. Immunoprecipitation showed that DHHC2 and DHHC3 predominantly bind to mature and immature tyrosinase, respectively. Taken together, tyrosinase palmitoylation at Cysteine500 by DHHC2, 3, and/or 15, especially DHHC2 in trans-Golgi apparatus and melanosomes and DHHC3 in the endoplasmic reticulum and cis-Golgi apparatus, regulate melanogenesis by modulating tyrosinase protein levels.